Page 5 - Bin Cao News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Analysis of 10 studies shows ivermectin not effective in treating COVID-19 A new meta-analysis of 10 studies shows ivermectin (IVM), an anti-parasite drug, is not an effective treatment for COVID-19 and is not a viable treatment option for patients. The study was published yesterday in Clinical Infectious Diseases. The authors analyzed results from 10 randomized control trials (RCTs) that included 1,173 patients total, and looked for IVM's effect on all-cause mortality, length of hospital stay, adverse events, and viral clearance compared to standard of care. COVID-19 patients had mild disea...

See eTable 1 in Supplement 2 for definitions of each analysis population. Among those receiving aluminum hydroxide (alum) for the first dose, 5 participants received WIV04 (n = 2) and HB02 (n = 3) vaccines for the second dose and were not included in the safety analysis population of the alum-only group (13 458 – 5 = 13 453), but were included in the WIV04 and HB02 groups, respectively. Three participants who received WIV04 for the first dose and HB02 for the second dose and 3 participants who received HB02 for the first dose and WIV04 for the second dose were included in both g...

eggeeggjiew / iStock Although nonhospitalized COVID-19 patients are at low risk for delayed complications, they visit their general practitioner or clinic more often than their uninfected peers in the 6 months after testing positive, finds a population-based study published yesterday in The Lancet Infectious Diseases. The study, led by researchers from the University of Southern Denmark, involved comparing 8,983 living, nonhospitalized COVID-19 patients with 80,894 Danish residents who tested negative for the virus from Feb 27 to May 31, 2020. Both groups were followed for 2 weeks to 6 month...

Published January 30, 2021, 9:41 PM PARIS—More than three quarters of people hospitalized with COVID-19 still suffered from at least one symptom after six months, according to a study published early this month that scientists said shows the need for further investigation into lingering coronavirus effects. The research, which was published in the Lancet medical journal and involved hundreds of patients in the Chinese city of Wuhan, is among the few to trace the long-term symptoms of COVID-19 infection. It found that fatigue or muscle weakness were the most common symptoms, while people als...

The symptoms COVID-19 Long Haulers can’t get rid of From the onset, the novel coronavirus was worrisome. It was new, virulent and its impact ranged from mild to deadly. Its victims seemed chosen at random, until the first data was gathered, and scientists began to see some patterns. So far, there have been more than 22 million diagnosed cases of COVID 19 in the United States, and infection numbers continue to skyrocket nationwide. Although the vaccine has started to roll out, the risk of infection remains. Most COVID-19 cases are mild, and some require hospitalization; experts estimate the...